PURA VIDA INVESTMENTS, LLC - Q3 2018 holdings

Add to watchlist

$475 Million is the total value of PURA VIDA INVESTMENTS, LLC's 106 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 78.7% .

All

			Value		Shares		↓ Weighting
ICUI	Sell	ICU MED INCcall	$9,048,000	-12.0%	32,000	-8.6%	1.90%	-53.8%
XBI	Sell	SPDR SER TRput	$4,794,000	-49.6%	50,000	-50.0%	1.01%	-73.6%
GMED	Sell	GLOBUS MED INCcl a	$3,264,000	-4.2%	57,500	-14.8%	0.69%	-49.7%
ZGNX	Sell	ZOGENIX INC	$2,218,000	+10.8%	44,718	-1.2%	0.47%	-41.8%
MYL	Sell	MYLAN NVcall	$1,830,000	-32.5%	50,000	-33.3%	0.38%	-64.5%
VRAY	Sell	VIEWRAY INCcall	$1,638,000	+18.4%	175,000	-12.5%	0.34%	-37.8%
QGEN	Sell	QIAGEN NVcall	$1,515,000	-58.1%	40,000	-60.0%	0.32%	-78.0%
IVC	Sell	INVACARE CORP	$1,455,000	-36.3%	100,000	-18.5%	0.31%	-66.6%
ARAY	Sell	ACCURAY INCcall	$1,125,000	-50.1%	250,000	-54.5%	0.24%	-73.8%
PRQR	Sell	PROQR THRAPEUTICS N V	$1,099,000	-44.5%	56,803	-79.1%	0.23%	-70.9%
RIGL	Sell	RIGEL PHARMACEUTICALS INC	$971,000	-37.6%	302,489	-45.0%	0.20%	-67.3%
OBSV	Sell	OBSEVA SA	$913,000	-33.0%	50,622	-43.8%	0.19%	-64.8%
MDGL	Sell	MADRIGAL PHARMACEUTICALS INC	$793,000	-78.4%	3,702	-71.7%	0.17%	-88.6%
FOMX	Exit	FOAMIX PHARMACEUTICALS LTD	$0	–	-24,100	-100.0%	-0.05%	–
CYTK	Exit	CYTOKINETICS INCcall	$0	–	-24,600	-100.0%	-0.08%	–
ITCI	Exit	INTRA CELLULAR THERAPIES INC	$0	–	-20,000	-100.0%	-0.14%	–
ARDX	Exit	ARDELYX INC	$0	–	-100,000	-100.0%	-0.15%	–
KMPH	Exit	KEMPHARM INC	$0	–	-60,000	-100.0%	-0.16%	–
VKTX	Exit	VIKING THERAPEUTICS INC	$0	–	-47,100	-100.0%	-0.18%	–
GBT	Exit	GLOBAL BLOOD THERAPEUTICS INcall	$0	–	-10,300	-100.0%	-0.19%	–
STAA	Exit	STAAR SURGICAL COcall	$0	–	-17,500	-100.0%	-0.22%	–
XNCR	Exit	XENCOR INC	$0	–	-15,000	-100.0%	-0.22%	–
TGTX	Exit	TG THERAPEUTICS INC	$0	–	-50,000	-100.0%	-0.26%	–
GERN	Exit	GERON CORPput	$0	–	-200,000	-100.0%	-0.28%	–
XENE	Exit	XENON PHARMACEUTICALS INC	$0	–	-75,000	-100.0%	-0.28%	–
MOTS	Exit	MOTUS GI HLDGS INC	$0	–	-100,000	-100.0%	-0.29%	–
FOLD	Exit	AMICUS THERAPEUTICS INCcall	$0	–	-50,000	-100.0%	-0.31%	–
BLUE	Exit	BLUEBIRD BIO INC	$0	–	-5,000	-100.0%	-0.32%	–
VKTX	Exit	VIKING THERAPEUTICS INCput	$0	–	-100,000	-100.0%	-0.38%	–
RCKT	Exit	ROCKET PHARMACEUTICALS INC	$0	–	-51,459	-100.0%	-0.40%	–
AKRXQ	Exit	AKORN INCcall	$0	–	-67,900	-100.0%	-0.45%	–
ANGO	Exit	ANGIODYNAMICS INC	$0	–	-50,842	-100.0%	-0.45%	–
TTOO	Exit	T2 BIOSYSTEMS INC	$0	–	-150,000	-100.0%	-0.46%	–
IMMU	Exit	IMMUNOMEDICS INC	$0	–	-50,400	-100.0%	-0.48%	–
COLL	Exit	COLLEGIUM PHARMACEUTICAL INC	$0	–	-52,219	-100.0%	-0.50%	–
CHRS	Exit	COHERUS BIOSCIENCES INCput	$0	–	-97,500	-100.0%	-0.55%	–
AVRO	Exit	AVROBIO INC	$0	–	-52,500	-100.0%	-0.60%	–
CORT	Exit	CORCEPT THERAPEUTICS INCput	$0	–	-100,200	-100.0%	-0.63%	–
ZGNX	Exit	ZOGENIX INCput	$0	–	-36,100	-100.0%	-0.64%	–
MRK	Exit	MERCK & CO. INC	$0	–	-30,000	-100.0%	-0.73%	–
CSII	Exit	CARDIOVASCULAR SYS INC DELcall	$0	–	-58,000	-100.0%	-0.75%	–
CARA	Exit	CARA THERAPEUTICS INCcall	$0	–	-100,000	-100.0%	-0.77%	–
HOLX	Exit	HOLOGIC INCcall	$0	–	-50,000	-100.0%	-0.80%	–
GKOS	Exit	GLAUKOS CORP	$0	–	-50,000	-100.0%	-0.81%	–
SRPT	Exit	SAREPTA THERAPEUTICS INC	$0	–	-16,000	-100.0%	-0.85%	–
GBT	Exit	GLOBAL BLOOD THERAPEUTICS INput	$0	–	-50,000	-100.0%	-0.91%	–
SIEN	Exit	SIENTRA INCcall	$0	–	-125,400	-100.0%	-0.98%	–
VRTX	Exit	VERTEX PHARMACEUTICALS INC	$0	–	-15,000	-100.0%	-1.02%	–
XENT	Exit	INTERSECT ENT INCput	$0	–	-70,000	-100.0%	-1.05%	–
SPPI	Exit	SPECTRUM PHARMACEUTICALS INCcall	$0	–	-130,700	-100.0%	-1.10%	–
SYNH	Exit	SYNEOS HEALTH INCcall	$0	–	-60,000	-100.0%	-1.13%	–
GKOS	Exit	GLAUKOS CORPcall	$0	–	-76,200	-100.0%	-1.24%	–
AGN	Exit	ALLERGAN PLC	$0	–	-20,000	-100.0%	-1.34%	–
ATHN	Exit	ATHENAHEALTH INC	$0	–	-21,000	-100.0%	-1.34%	–
HOLX	Exit	HOLOGIC INC	$0	–	-87,500	-100.0%	-1.39%	–
SIEN	Exit	SIENTRA INC	$0	–	-183,900	-100.0%	-1.44%	–
GWPH	Exit	GW PHARMACEUTICALS PLCcall	$0	–	-30,000	-100.0%	-1.68%	–
MTD	Exit	METTLER TOLEDO INTERNATIONALput	$0	–	-10,000	-100.0%	-2.32%	–
CNC	Exit	CENTENE CORP DELcall	$0	–	-50,000	-100.0%	-2.47%	–
BSX	Exit	BOSTON SCIENTIFIC CORPcall	$0	–	-200,000	-100.0%	-2.62%	–
ATHN	Exit	ATHENAHEALTH INCcall	$0	–	-72,500	-100.0%	-4.62%	–

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR/A filed 2021-02-11

Signatures

The EDGAR filing(s) were signed by:

Alyssa Romano — Chief Compliance Officer and Chief Financial Officer

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
ICU MED INC	26	Q2 2023	4.2%
NANOSTRING TECHNOLOGIES INC	26	Q2 2023	3.3%
VIEWRAY INC	25	Q2 2023	3.2%
LIVANOVA PLC	23	Q3 2023	3.8%
ALEXION PHARMACEUTICALS INC	23	Q1 2021	4.3%
INSPIRE MED SYS INC	22	Q3 2023	3.7%
BOSTON SCIENTIFIC CORP	22	Q3 2022	4.8%
INVACARE CORP	22	Q3 2021	2.8%
ESTABLISHMENT LABS HLDGS INC	21	Q3 2023	5.0%
INTERSECT ENT INC	21	Q2 2021	2.6%

View PURA VIDA INVESTMENTS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

PURA VIDA INVESTMENTS, LLC Q3 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Stryve Foods Holdings, LLC	April 19, 2023	1,470,649	5.6%
ICAD INC	March 15, 2023	1,277,214	5.0%
ESTABLISHMENT LABS HOLDINGS INC.	February 14, 2023	1,002,767	4.1%
Pulmonx Corp	February 14, 2023	1,216,258	3.2%
Quotient Ltd^{Sold out}	February 14, 2023	0	0.0%
Universe Pharmaceuticals INC^{Sold out}	February 14, 2023	0	0.0%
MedMen Enterprises, Inc.	April 29, 2022	139,755,072	21.4%
INVACARE CORP^{Sold out}	February 14, 2022	0	0.0%
MedAvail Holdings, Inc.	February 14, 2022	714,120	2.2%
TELA Bio, Inc.	February 14, 2022	564,120	3.9%

View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.

Latest filings

Type	Filed
13F-HR	2024-05-15
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
13F-HR	2024-02-13

View PURA VIDA INVESTMENTS, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

The reported total value is incorrect (475364000.0 != 475368000.0)
The reported has been restated
The reported has been amended

Export PURA VIDA INVESTMENTS, LLC's holdings